Chief Development Officer · Revolution Medicines, Inc. · Common Stock
Side
SELL
Value
$244K
Shares
1,199
Price
$203.91
Executed
Sep 29, 2026
Disclosed
Oct 1, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Sep 29 executedOct 1, 2026 disclosed
RVMD · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+4 / 15
2 prior trades recorded in this security
Frequency & clustering+15 / 15
4 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Sandler Alan B. filed this Form 4 reporting a open-market sale of RVMD on Sep 29, 2026. It became public on Oct 1, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Development Officer
Sandler Alan B.cik:0001835966
Issuer
Revolution Medicines, Inc.cik:0001628171
Revision history · 0
No field has changed since this record was first ingested.
